Skip to main content
Erschienen in: Tumor Biology 5/2012

01.10.2012 | Research Article

Burden of cancers in the valley of Kashmir: 5 year epidemiological study reveals a different scenario

verfasst von: Arshad A. Pandith, Mushtaq A. Siddiqi

Erschienen in: Tumor Biology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Cancer is a major burden worldwide but there are marked geographical variations in frequency and incidence overall. The aim of this study was to find the frequency and distribution of commonly occurring cancers in Kashmir, with particular emphasis on urinary bladder cancer. A total of 4,407 cases of histologically confirmed new cancer cases were registered at the Medical Records Department (MRD) of SKIMS from a period between January, 2005 and April 2010. Among 4407 cancers, 2,457 (55.7 %) were men and 1,950 (44.3 %) were women. Stomach cancer is the leading one with an average frequency of 19.2 % followed by esophagus and lung as 16.5 % and 14.6 %, respectively. Stomach (23 %) and lung (21 %) are the leading cancers in men while as esophageal cancer tops (18.3 %) in women followed by breast cancer (16.6 %). This distribution of cancer types is strikingly different from that in the rest of India where oropharyngeal cancer is most common form. Among urinogenital cancers, bladder cancer was observed to primarily affect Kashmiri population (5.9 %) followed by prostate cancer (2.1 %) and renal carcinoma (1.1 %). We conclude that Kashmir is a very high risk area of most commonly occurring cancers particularly cancers of gastrointestinal tract which comprise more than half the frequency of all the cancers.
Literatur
1.
Zurück zum Zitat Garcia M, Jemal A, Ward EM, et al. Global cancer facts and figures 2007. American Cancer Society, Atlanta. Garcia M, Jemal A, Ward EM, et al. Global cancer facts and figures 2007. American Cancer Society, Atlanta.
2.
Zurück zum Zitat Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5.version 2.0. Lyon: IARC Press; 2004. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5.version 2.0. Lyon: IARC Press; 2004.
3.
Zurück zum Zitat Boyle P, Levin B, editors. World Cancer Report 2008. Lyon: International Agency for Research on Cancer; 2008. Boyle P, Levin B, editors. World Cancer Report 2008. Lyon: International Agency for Research on Cancer; 2008.
5.
Zurück zum Zitat Nanda KA. Consolidated report of the population based cancer registries, incidence and distribution of cancer, 1990–1996. National Cancer Registry Program, New Delhi: Indian Council of Medical research; 2001. Nanda KA. Consolidated report of the population based cancer registries, incidence and distribution of cancer, 1990–1996. National Cancer Registry Program, New Delhi: Indian Council of Medical research; 2001.
6.
Zurück zum Zitat World Health Organization. A decade of health development in SE Asia, 1968–1977. New Delhi: SEARO; 1978. World Health Organization. A decade of health development in SE Asia, 1968–1977. New Delhi: SEARO; 1978.
7.
Zurück zum Zitat IARC. Schistosomes, liver flukes and Helicobacter pylori, IARC monographs, vol. 61. Lyon: IARC; 1994. IARC. Schistosomes, liver flukes and Helicobacter pylori, IARC monographs, vol. 61. Lyon: IARC; 1994.
8.
Zurück zum Zitat Kmet J, Mahboubi E. Gesophageal cancer in the Caspian littoral of Iran: initial studies. Science. 1972;175:846–52.CrossRefPubMed Kmet J, Mahboubi E. Gesophageal cancer in the Caspian littoral of Iran: initial studies. Science. 1972;175:846–52.CrossRefPubMed
9.
Zurück zum Zitat Yang CS. Research on oesophageal cancer in China: a review. Cancer Res. 1980;40:2633–44.PubMed Yang CS. Research on oesophageal cancer in China: a review. Cancer Res. 1980;40:2633–44.PubMed
10.
Zurück zum Zitat Warwick GP. Some aspects of the epidemiology and aetiology of esophageal cancer with particular emphasis on the Transkei, South Africa. Adv Cancer Res. 1973;17:81–229.CrossRef Warwick GP. Some aspects of the epidemiology and aetiology of esophageal cancer with particular emphasis on the Transkei, South Africa. Adv Cancer Res. 1973;17:81–229.CrossRef
11.
Zurück zum Zitat Siddiqi M, Preussmann R. Oesophageal cancer in Kashmir—an assessment. J Cancer Res Clin Oncol. 1989;115:111–7.CrossRefPubMed Siddiqi M, Preussmann R. Oesophageal cancer in Kashmir—an assessment. J Cancer Res Clin Oncol. 1989;115:111–7.CrossRefPubMed
12.
13.
Zurück zum Zitat Tricker AR, Siddiqi M, Preussmann R. Occurrence of volatile N-nitrosoamines in dried chillies. Cancer Leu. 1988;38:271–3.CrossRef Tricker AR, Siddiqi M, Preussmann R. Occurrence of volatile N-nitrosoamines in dried chillies. Cancer Leu. 1988;38:271–3.CrossRef
14.
Zurück zum Zitat Siddiqi M, Tricker AR, Preussmann R. The occurrence of preformed N-nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir, India. Cancer Leu. 1988;39:37–43.CrossRef Siddiqi M, Tricker AR, Preussmann R. The occurrence of preformed N-nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir, India. Cancer Leu. 1988;39:37–43.CrossRef
15.
Zurück zum Zitat Waterhouse J, Shanmugaratnam K, et al. Cancer incidence in five continents. Lyon: IARC; 1982. p. 390–7. IARC Scientific Publication no 42. Waterhouse J, Shanmugaratnam K, et al. Cancer incidence in five continents. Lyon: IARC; 1982. p. 390–7. IARC Scientific Publication no 42.
16.
Zurück zum Zitat Siddiqi M, Tricker AR, Preussmann R. Formation of N-nitroso compounds under simulated gastric conditions from Kashmir food stuffs. Cancer Leu. 1988;39:259–65.CrossRef Siddiqi M, Tricker AR, Preussmann R. Formation of N-nitroso compounds under simulated gastric conditions from Kashmir food stuffs. Cancer Leu. 1988;39:259–65.CrossRef
17.
Zurück zum Zitat Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents, vol. VII, International Agency for Research on Cancer (IARC). Lyon: IARC; 1997. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents, vol. VII, International Agency for Research on Cancer (IARC). Lyon: IARC; 1997.
18.
Zurück zum Zitat Koul PA, Koul SK. Epidemiology of lung cancer in Kashmir Valley. Annuals of Thoracic Medicine. Thesis submitted to the Sheri Kashmir Institute of Medical Sciences University; 2007. Koul PA, Koul SK. Epidemiology of lung cancer in Kashmir Valley. Annuals of Thoracic Medicine. Thesis submitted to the Sheri Kashmir Institute of Medical Sciences University; 2007.
19.
Zurück zum Zitat Khan NA, Firafroz, Lone MM, et al. Profile of lung cancer in Kashmir India. A five year study. Indian J Chest Dis and Allied Sci. 2006;48:185–8. Khan NA, Firafroz, Lone MM, et al. Profile of lung cancer in Kashmir India. A five year study. Indian J Chest Dis and Allied Sci. 2006;48:185–8.
20.
Zurück zum Zitat Behera D, Balamugesh T. Lung cancer in India. Indian J Chest Dis and allied Sci. 2004;46:269–81. Behera D, Balamugesh T. Lung cancer in India. Indian J Chest Dis and allied Sci. 2004;46:269–81.
21.
Zurück zum Zitat Ernest LW, Kiychiko M, Edward JB. The epidemiology of lung cancer. JAMA. 1970;213:2221–7.CrossRef Ernest LW, Kiychiko M, Edward JB. The epidemiology of lung cancer. JAMA. 1970;213:2221–7.CrossRef
22.
Zurück zum Zitat Wynder EL, Munskinski M. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer. 1977;40:1872–8.CrossRefPubMed Wynder EL, Munskinski M. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer. 1977;40:1872–8.CrossRefPubMed
23.
Zurück zum Zitat Taylor J, Piper DW. The carcinogenic effect of cigarette smoke. The effect of cigarette smoke on human gastric mucosal cell in organ cultures. Cancer. 1971;39:2520.CrossRef Taylor J, Piper DW. The carcinogenic effect of cigarette smoke. The effect of cigarette smoke on human gastric mucosal cell in organ cultures. Cancer. 1971;39:2520.CrossRef
24.
Zurück zum Zitat Arya SN, Kumar R, Snajay A. Hazards of smoking. Indian Med Assoc. 1991;89:98–100. Arya SN, Kumar R, Snajay A. Hazards of smoking. Indian Med Assoc. 1991;89:98–100.
25.
Zurück zum Zitat Karim-Kos HE, De Vries E, Soerjomataram I, et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345–89.CrossRefPubMed Karim-Kos HE, De Vries E, Soerjomataram I, et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345–89.CrossRefPubMed
26.
27.
Zurück zum Zitat Arshad AP, Zafar S, Roohi R, et al. Activated H-ras gene mutations in transitional cell carcinoma of urinary the bladder in a Kashmiri population. Tumori. 2010;96:993–8. Arshad AP, Zafar S, Roohi R, et al. Activated H-ras gene mutations in transitional cell carcinoma of urinary the bladder in a Kashmiri population. Tumori. 2010;96:993–8.
28.
Zurück zum Zitat Coleman MP, Esteve J, Damiecki P, et al. Trends in cancer incidence and mortality, International Agency for Research on Cancer (IARC), Scientific Publication 121. Lyon: IARC; 1993. Coleman MP, Esteve J, Damiecki P, et al. Trends in cancer incidence and mortality, International Agency for Research on Cancer (IARC), Scientific Publication 121. Lyon: IARC; 1993.
29.
Zurück zum Zitat Neve A. Kangri-bum epithelioma in Kashmir. Ind Med Gaz. 1990;35:81–3. Neve A. Kangri-bum epithelioma in Kashmir. Ind Med Gaz. 1990;35:81–3.
31.
Zurück zum Zitat Neve EF. Kangri-bum cancer. Ind Med Gaz. 1941;76:138–40. Neve EF. Kangri-bum cancer. Ind Med Gaz. 1941;76:138–40.
32.
Zurück zum Zitat Shera AH, Bhan BM. Clinicopathological behavior of Kangri cancer. Ind J Surg. 1986;48:233–8. Shera AH, Bhan BM. Clinicopathological behavior of Kangri cancer. Ind J Surg. 1986;48:233–8.
33.
Zurück zum Zitat Sanyal B, Shastri SR, Hakim A, et al. A clinical profile of skin cancer from Kashmir valleywith special reference to “Kangri” cancer. J Clin Radiother Oncol. 1989;4:31–6. Sanyal B, Shastri SR, Hakim A, et al. A clinical profile of skin cancer from Kashmir valleywith special reference to “Kangri” cancer. J Clin Radiother Oncol. 1989;4:31–6.
34.
Zurück zum Zitat Treves N, Pack GT. The development of cancer in bum scars. Surg Gynecol Obstet. 1930;51:749–82. Treves N, Pack GT. The development of cancer in bum scars. Surg Gynecol Obstet. 1930;51:749–82.
35.
Zurück zum Zitat Perin N, Notani. Global variation in cancer incidence and mortality. Current Science. 2001;81(5):465–74. Perin N, Notani. Global variation in cancer incidence and mortality. Current Science. 2001;81(5):465–74.
Metadaten
Titel
Burden of cancers in the valley of Kashmir: 5 year epidemiological study reveals a different scenario
verfasst von
Arshad A. Pandith
Mushtaq A. Siddiqi
Publikationsdatum
01.10.2012
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 5/2012
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-012-0418-z

Weitere Artikel der Ausgabe 5/2012

Tumor Biology 5/2012 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.